Promising study on treating core symptoms in Rett syndrome supports further trials

Vanderbilt Kennedy Center (VKC) Director Jeffrey Neul, M.D., Ph.D., and colleagues studied the safety and effectiveness of the drug trofinetide in female children and adolescents (age 5-15) with Rett syndrome (RTT). Findings were recently published in…
Read more